| Members |
targetComponentId |
| Fetus with damage due to other maternal disease unspecified |
Fetal disorder due to disease in mother (disorder) |
| Fetus with damage due to other maternal disease with antenatal problem |
Fetal disorder due to disease in mother (disorder) |
| Fetus with drug damage with antenatal problem |
Fetal disorder caused by drug or medicament |
| Fetus with hereditary disease NOS |
Fetal hereditary disease |
| Fetus with hereditary disease unspecified |
Fetal hereditary disease |
| Fetus with hereditary disease with antenatal problem |
Fetal hereditary disease |
| Fetus with maternal problem NOS |
Fetal disorder due to disease in mother (disorder) |
| Fetus with maternal problem NOS |
Fetal disorder due to disease in mother (disorder) |
| Fetus with radiation damage |
Fetal disorder caused by ionising radiation |
| Fetus with radiation damage - delivered |
Fetal disorder caused by ionising radiation |
| Fetus with radiation damage NOS |
Fetal disorder caused by ionising radiation |
| Fetus with radiation damage unspecified |
Fetal disorder caused by ionising radiation |
| Fetus with radiation damage with antenatal problem |
Fetal disorder caused by ionising radiation |
| Fetus with viral damage via mother with antenatal problem |
Fetal damage due to maternal viral infection (disorder) |
| Fexofenadine 30mg/5mL oral suspension |
Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Fexofenadine hydrochloride + pseudoephedrine hydrochloride 60mg/120mg tablet |
Fexofenadine and pseudoephedrine only product |
| Fexofenadine hydrochloride 180mg m/r tablet |
Fexofenadine only product in oral dose form |
| Fexofenadine hydrochloride 180mg prolonged-release oral tablet |
Fexofenadine only product in oral dose form |
| Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg m/r tablet |
Fexofenadine and pseudoephedrine only product |
| Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg prolonged-release oral tablet |
Fexofenadine and pseudoephedrine only product |
| Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg m/r tablet |
Fexofenadine and pseudoephedrine only product |
| Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg prolonged-release oral tablet |
Fexofenadine and pseudoephedrine only product |
| Fiancé of subject |
Fiance |
| Fiber |
Plant fiber |
| Fiberlight anesthetic laryngoscope |
Fibreoptic laryngoscope |
| Fiberoptic esophagoscopy NEC |
Endoscopy of esophagus |
| Fibreoptic bronchoscopy: [diagnostic NOS] or [NEC] |
Fibreoptic bronchoscopy |
| Fibreoptic oesophagoscopy: [diagnostic NOS] or [NEC] |
Endoscopy of esophagus |
| Fibrin AND/OR fibrinogen agent |
Coagulation related substance (substance) |
| Fibrinolysis - postpartum |
Postpartum disorder of abnormal fibrinolysis (disorder) |
| Fibrinolytic system finding |
Disorder involving the fibrinolytic system |
| Fibroadenoma, no International Classification of Diseases for Oncology subtype |
Benign fibroadenoma (morphologic abnormality) |
| Fibrocalculous pancreatopathy without complication |
Fibrocalculous pancreatic diabetes |
| Fibrocystic disease |
Nonproliferative fibrocystic disease (morphologic abnormality) |
| Fibrohistiocytic neoplasm - category |
Fibrohistiocytic neoplasm (morphologic abnormality) |
| Fibroma, no International Classification of Diseases for Oncology subtype |
Benign fibroma |
| Fibromyalgia |
Fibromyositis |
| Fibrous papule of the nose |
Fibrous papule of nose |
| Fibula X-ray |
Plain X-ray of fibula (procedure) |
| Fifth day fits |
Self-limited neonatal epilepsy (disorder) |
| Fifth ventricle |
Structure of cave of septum pellucidum (body structure) |
| Filaricides |
Anthelmintic |
| File root canal |
Root canal preparation |
| Filgrastim 30million units/mL injection solution 1mL vial |
Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Filgrastim 48million units/mL injection solution 1.6mL vial |
Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Film production NOS |
Motion picture producer |
| Film production NOS |
Motion picture producer |
| Film-coated capsule |
Capsule |
| Final report |
Final report (record artifact) |
| Finance/investment specialist NOS |
Finance/investment specialist (occupation) |
| Finance/investment specialist NOS |
Finance/investment specialist (occupation) |
| Finance/investment/insurance clerk NOS |
Finance/investment/insurance clerk |
| Finance/investment/insurance clerk NOS |
Finance/investment/insurance clerk |
| Finances case management |
Management of financial circumstance (procedure) |
| Finding |
Clinical finding (finding) |
| Finding by site |
Clinical finding (finding) |
| Finding of Aspergillus species not Aspergillus fumigatus |
Aspergillus species not Aspergillus fumigatus (organism) |
| Finding of Bacillus species not anthracis |
Bacillus species not Bacillus anthracis (organism) |
| Finding of Candida, not Candida albicans |
Candida species not Candida albicans (organism) |
| Finding of Clostridium, not Clostridium perfringens |
Clostridium species, not Clostridium perfringens (organism) |
| Finding of Corynebacterium species, not Corynebacterium diphtheriae |
Corynebacterium species, not Corynebacterium diphtheriae (organism) |
| Finding of Corynebacterium species, not group JK |
Corynebacterium species not Corynebacterium jeikeium (organism) |
| Finding of Mobiluncus-like gram-negative rod organism |
Mobiluncus-like gram-negative bacillus (organism) |
| Finding of Moraxella catarrhalis, beta lactamase positive |
Moraxella catarrhalis, beta lactamase positive (organism) |
| Finding of Moraxella-like organism |
Moraxella-like organism (organism) |
| Finding of Moraxella-resembling organism |
Moraxella-like organism (organism) |
| Finding of Mycobacterium Group 4 not Mycobacterium fortuitum complex |
Rapid growing Mycobacterium species not Mycobacterium fortuitum complex (organism) |
| Finding of Mycobacterium species not Mycobacterium tuberculosis |
Mycobacterium, non-TB |
| Finding of Mycoplasma species |
Genus Mycoplasma |
| Finding of Mycoplasma species and ureaplasma positive |
Genus Mycoplasma |
| Finding of Mycoplasma species, not Mycoplasma pneumoniae |
Mycoplasma species, not Mycoplasma pneumoniae (organism) |
| Finding of Neisseria gonorrhoeae, beta lactamase negative |
Neisseria gonorrhoeae, beta lactamase negative (organism) |
| Finding of Neisseria species not Neisseria gonococci |
Neisseria species not Neisseria gonococci (organism) |
| Finding of Plasmodium species not Plasmodium falciparum |
Plasmodium species not Plasmodium falciparum |
| Finding of Pneumocystis carinii present |
Pneumocystis jirovecii present (finding) |
| Finding of absence of iris |
Congenital aniridia (disorder) |
| Finding of active range of ankle extension |
Finding of active range of ankle plantar flexion (finding) |
| Finding of active range of ankle flexion |
Finding of active range of ankle dorsiflexion |
| Finding of arrangement of female pelvis |
Finding of arrangement of pelvis |
| Finding of arrangement of umbilical cord |
Arrangement of umbilical cord |
| Finding of blood drug level |
Finding of blood substance level |
| Finding of blood toxic substance level |
Finding of blood substance level |
| Finding of body region |
Clinical finding (finding) |
| Finding of cataract form |
Cataract |
| Finding of color of amniotic fluid |
Amniotic fluid appearance - finding |
| Finding of decreased risk level |
Finding of low risk level (finding) |
| Finding of drug and poison levels |
Finding of substance level (finding) |
| Finding of estimated date of delivery |
Estimated date of delivery |
| Finding of functional performance and activity |
Clinical finding (finding) |
| Finding of measure of fit (seizure) |
Seizure related finding |
| Finding of measures of umbilical cord |
Measure of umbilical cord |
| Finding of mixed deceleration |
Early and late fetal heart decelerations (finding) |
| Finding of mold resembling coccidiodes immitis |
Mold resembling Coccidioides immitis (organism) |
| Finding of observations of measures of seizures |
Seizure related finding |
| Finding of passive range of ankle extension |
Finding of passive range of ankle plantar flexion (finding) |
| Finding of passive range of ankle flexion |
Finding of passive range of ankle dorsiflexion |
| Finding of poison level |
Finding of substance level (finding) |
| Finding of presence of drug |
Finding of substance level (finding) |
| Finding of presence of poison |
Poisoning |
| Finding of prolonged deceleration |
Prolonged fetal heart deceleration |
| Finding of proportion of female pelvis |
Proportion of female pelvis |
FHIR